Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-07-22
DOI
10.1038/s41467-022-31997-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture
- (2020) James R. Turk et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics
- (2020) Jonas Bovijn et al. Science Translational Medicine
- VSMC-specific EP4 deletion exacerbates angiotensin II-induced aortic dissection by increasing vascular inflammation and blood pressure
- (2019) Hu Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Vascular smooth muscle cells in atherosclerosis
- (2019) Gemma L. Basatemur et al. Nature Reviews Cardiology
- HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
- (2019) Chao Liang et al. Nature Communications
- A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis
- (2018) E Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- PSRC1 overexpression attenuates atherosclerosis progression in apoE −/− mice by modulating cholesterol transportation and inflammation
- (2018) Kai Guo et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- A newly identified lncRNA MAR1 acts as a miR-487b sponge to promote skeletal muscle differentiation and regeneration
- (2018) Zong-Kang Zhang et al. Journal of Cachexia Sarcopenia and Muscle
- Inhibition of osteoblastic Smurf1 promotes bone formation in mouse models of distinctive age-related osteoporosis
- (2018) Chao Liang et al. Nature Communications
- Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
- (2017) Zhenjian Zhuo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Monocytes and macrophages in abdominal aortic aneurysm
- (2017) Juliette Raffort et al. Nature Reviews Cardiology
- Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
- (2017) Kenneth G. Saag et al. NEW ENGLAND JOURNAL OF MEDICINE
- A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
- (2017) Fangfei Li et al. Nature Communications
- Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL
- (2017) Baocai Wang et al. Biology Open
- Size, Shape, and Sequence-Dependent Immunogenicity of RNA Nanoparticles
- (2017) Sijin Guo et al. Molecular Therapy-Nucleic Acids
- Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II–Induced Aortic Aneurysm and AtherosclerosisHighlights
- (2016) Smriti Murali Krishna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
- (2016) Defang Li et al. Nature Communications
- Heme oxygenase-1 deficiency exacerbates angiotensin II-induced aortic aneurysm in mice
- (2016) Yen-Chun Ho et al. Oncotarget
- Pharmacokinetics and tolerability of NSC23925b, a novel P-glycoprotein inhibitor: preclinical study in mice and rats
- (2016) Yan Gao et al. Scientific Reports
- G-quadruplex aptamer targeting Protein A and its capability to detect Staphylococcus aureus demonstrated by ELONA
- (2016) Regina Stoltenburg et al. Scientific Reports
- A delivery system specifically approaching bone resorption surfaces to facilitate therapeutic modulation of microRNAs in osteoclasts
- (2015) Jin Liu et al. BIOMATERIALS
- The Effects of Atorvastatin on the Prevention of Osteoporosis and Dyslipidemia in the High-Fat-Fed Ovariectomized Rats
- (2015) Sien Lin et al. CALCIFIED TISSUE INTERNATIONAL
- Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference–based bone anabolic strategy
- (2015) Chao Liang et al. NATURE MEDICINE
- Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice
- (2015) Katherine Perschbacher et al. Nucleic Acid Therapeutics
- Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
- (2015) Dae Hyun Kim et al. PLoS One
- Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition
- (2013) Verena Boschert et al. PLoS One
- ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion
- (2012) Jolanta M. Siller-Matula et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy
- (2012) Ge Zhang et al. NATURE MEDICINE
- miR-214 targets ATF4 to inhibit bone formation
- (2012) Xiaogang Wang et al. NATURE MEDICINE
- Identification of a DNA aptamer that inhibits sclerostin's antagonistic effect on Wnt signalling
- (2011) Ka To Shum et al. BIOCHEMICAL JOURNAL
- Patients with sclerosteosis and disease carriers: Human models of the effect of sclerostin on bone turnover
- (2011) Antoon H van Lierop et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE−/−mice
- (2010) Alan Daugherty et al. CLINICAL SCIENCE
- First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function
- (2010) Elke Piters et al. HUMAN MUTATION
- Development of DNA aptamers using Cell-SELEX
- (2010) Kwame Sefah et al. Nature Protocols
- Genetic Mosaic Dissection of Lis1 and Ndel1 in Neuronal Migration
- (2010) Simon Hippenmeyer et al. NEURON
- Characterization of the Structural Features and Interactions of Sclerostin
- (2009) Vaclav Veverka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The CMV early enhancer/chicken β actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors
- (2008) Annika N Alexopoulou et al. BMC CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search